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Answers
1. The possible etiologies of crystalluria in an infant include hypercalciuria, distal RTA (d-
RTA), primary hyperoxaluria, cystinuria, hyperuricosuria and rarely due to increased 
excretion of other purine and pyrimidine metabolites such as 2,8-dihydroxyadenine, 
xanthine, hypoxanthine and orotic acid[1]. Our patient did not have evidence of metabolic 
acidosis, hypercalciuria, hypocitraturia, hyperoxaluria or aminoaciduria thereby ruling out 
crystalluria secondary to disorders causing hypercalciuria, d-RTA, primary hyperoxaluria, 
and cystinuria. We therefore focused further investigation on disorders of purine metabolism 
which can present with altered uric acid levels in plasma and urine [2]. Hyperuricosuria may 
be physiologic due to increased excretion of uric acid in neonates. Hyperuricosuria with 
hyperuricemia may be associated with hypoxanthine-guanine phosphoribosyl transferase 
(HPGRT) deficiency and glycogen storage disorders. Hypouricosuria can be seen in 
xanthine dehydrogenase (XDH) deficiency which is associated with increased excretion of 
xanthine and hypoxanthine. Adenine phosphoribosyl transferase (APRT) deficiency leads to 
increased urinary 2,8-dihydroxyadenine (2,8-DH) with uric acid excretion being normal [3].
2. Further testing should include:
• Urinary uric acid-to-creatinine ratio and fractional excretion of uric acid (FeUA).
• APRT enzyme activity in erythrocyte lysates – abolished enzyme activity confirms 
APRT deficiency.
• Urinary xanthine- and hypoxanthine-to-creatinine ratios – increased excretion and 
low FeUA is suggestive of xanthinuria
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• Urine sulfocysteine (SO) level to evaluate for molybdenum cofactor deficiency, 
which can be associated with xanthinuria.
In our patient, increased urinary excretion of xanthine and hypoxanthine and low FeUA 
along with severe hypouricemia, normal APRT enzyme activity and normal SO level, were 
diagnostic of hereditary xanthinuria.
3. Hypouricemia can be associated with several conditions which can be further classified 
based on FeUA. Low FeUA is seen in hereditary xanthinuria and is also associated with the 
use of allopurinol or rasburicase, and low dietary purine intake. Hypouricemia with normal 
to high FeUA is seen in hereditary renal hypouricemia, syndrome of inappropriate 
antidiuretic hormone, and conditions causing generalized proximal tubulopathy such as 
Wilson’s disease, Fanconi syndrome and cystinosis [4]. Hypouricemia to the degree of 
severity seen in our patient is rarely seen in conditions other than xanthinuria or hereditary 
renal hypouricemia while patients with APRT deficiency have mild hypouricemia.
Commentary
Urinary crystals in this patient did not resemble uric acid or cystine crystals and in fact, did 
not resemble any commonly found urinary crystals. Literature review revealed the crystals 
to closely resemble 2,8-DHA almost exclusively seen in patients with untreated APRT 
deficiency. APRT deficiency (OMIM: 614723) is a rare, inherited disorder of purine 
metabolism that leads to excessive urinary excretion of the highly insoluble 2,8-DHA 
crystals which causes kidney stones, chronic kidney disease and even end-stage renal 
disease. Diagnosis is confirmed by stone infrared spectrophotometry and measurement of 
APRT activity in red blood cell lysates which can be abolished or diminished[5, 6]. Serum 
uric acid level is normal or mildly reduced in patients with normal kidney function and 
FeUA is normal [3, 6] [Unpublished observation, V. Edvardsson Jan 20, 2015]. Although 
the proband’s crystals resembled 2,8-DHA, his APRT enzyme activity in erythrocyte lysate 
was normal at 36 nmol/h/mgHB (reference range 17–32 nmol/h/mgHB) excluding this 
diagnosis.
The findings of increased urinary excretion of xanthine and hypoxanthine, at 203 mmol/mol 
creatinine (Cr) (reference <53mmol/mol Cr) and 414 mmol/mol Cr (reference <49mmol/mol 
Cr), respectively, extremely low fractional excretion of uric acid at 0.25% (normal 
7.28±2.9%) and the severe hypouricemia in our patient were highly suggestive of hereditary 
xanthinuria. Urine sulfocysteine level was normal at 7 micromol/g Cr (reference range 
<80micromol/g Cr) thus ruling out molybdenum cofactor deficiency as the cause of 
xanthinuria. Genetic testing of the proband revealed one previously described heterozygous 
mutation, T910M, in exon 25 of the xanthine dehydrogenase (XDH) gene (c.2729C>T) and 
a second, previously unidentified, heterozygous variant, R830C, in exon 23 of the XDH gene 
(c.2488C>T). [7, 8]. The proband’s asymptomatic mother was heterozygous for the T910M 
mutation and his asymptomatic father was heterozygous for the R830C variant.
Further management of our patient involved a low purine diet in addition to maintenance of 
hydration especially in the face of an acute illness. One and a half year after initial 
presentation, body weight has increased to the 27th percentile and height to the 61st 
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percentile. The child is mostly asymptomatic but is still noted to have crystals in first 
morning urine samples, especially during episodes of acute illness. Microscopic examination 
of first morning urine specimens on multiple occasions has failed to show any crystals 
during illness free periods. However, urine xanthine- and hypoxanthine-to-creatinine ratios 
(mmol/mol) remain elevated at 731 and 248, respectively. Repeat renal ultrasound 
examinations have been normal.
Hereditary xanthinuria is an autosomal recessive disorder of purine metabolism most 
commonly manifesting with urolithiasis and in rare cases, renal failure due to crystal 
nephropathy [9]. The disorder is caused by mutations in the XDH gene located on 
chromosome 2p23 causing deficiency of the XDH enzyme responsible for degradation of 
hypoxanthine and xanthine to uric acid [10]. Deficiency of XDH results in markedly 
diminished production of uric acid and elevated xanthine and hypoxanthine levels in plasma 
and urine (Figure 1). High renal clearance and extreme insolubility at any physiological pH 
can cause xanthine crystal precipitation in the renal tubules leading to crystalluria, 
hematuria, urorolithiasis, and in severe cases, renal failure [9]. Infants can additionally 
present with urinary tract infection and failure to thrive. No satisfactory explanation for the 
latter association is available in the literature. Renal manifestations can present at any age, 
with more than 50 percent occurring in children younger than 10 years of age. In older 
patients, accumulation of xanthine in extra-renal tissues may cause duodenal ulcers, 
myopathy or arthropathy. About 20 percent of patients have been reported to be 
asymptomatic [9]. The incidence appears to be higher in Mediterranean and Middle Eastern 
populations [11, 12].
Hereditary xanthinuria is classified into two types based on the type of enzyme deficiency. 
In type I (OMIM 278300), there is an isolated deficiency of XDH whereas in type II 
(OMIM: 603592), there is an additional deficiency of the enzyme aldehyde oxidase (AOX) 
responsible for metabolism of allopurinol [13]. Diagnosis is made by identification of 
crystals, high urinary xanthine and hypoxanthine levels, low serum uric acid levels and low 
FeUA. Genetic testing is also available. To date there are seven reported mutations causing 
xanthinuria type 1 in the Human Gene Mutation Database (HGMD®) [14]. Four of these are 
nonsense or missense mutations, two are small deletions and one constitutes a small 
insertion [7, 10, 12, 15–17].
Xanthinuria can also be associated with molybdenum cofactor deficiency (OMIM: 252150) 
where sulfite oxidase (SO) is also inactive in addition to XDH and AOX and is characterized 
by severe neurologic involvement. Molybdenum cofactor is essential for the function of the 
SO, XDH and AOX. Diagnosis is made on the basis of hypouricemia and elevated urinary 
xanthine and S-sulfocysteine levels [18].
Hereditary xanthinuria is managed with high fluid intake and a diet low in purines. Urine 
alkalinization is ineffective as xanthine is insoluble at any physiological pH. Response to 
treatment can be monitored by urine microscopy looking for crystalluria, and by periodic 
monitoring of urinary xanthine and hypoxanthine excretion.
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Conclusion
This clinical quiz highlights the importance of urine microscopy performed by the clinician 
for detection of crystalluria. It is important to examine a first morning specimen for the best 
yield. It is alarming to note that manual urine microscopy is not routinely performed in 
many nephrology practices and comes at the cost of losing valuable information gained from 
this simple procedure [19]. Importantly, this case also underscores the significance of severe 
hypouricemia as an important laboratory finding that can aid in diagnosis of a child 
presenting with urinary crystals.
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Figure 1. 
Schematic overview of purine metabolism.
Abbreviations: DNA, deoxyribonucleic acid; RNA, ribonucleic acid; XDH, xanthine 
dehydrogenase.
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